Recent development of potent analogues of oxazolidinone antibacterial agents

被引:101
作者
Michalska, Katarzyna [1 ]
Karpiuk, Izabela [1 ]
Krol, Marek [2 ]
Tyski, Stefan [1 ,3 ]
机构
[1] Natl Med Inst, Dept Antibiot & Microbiol, PL-00725 Warsaw, Poland
[2] Med Univ Warsaw, Dept Drug Technol & Pharmaceut Biotechnol, PL-00725 Warsaw, Poland
[3] Med Univ Warsaw, Dept Pharmaceut Microbiol, PL-02007 Warsaw, Poland
关键词
Oxazolidinones; Linezolid; Drug discovery; Antibacterial agents; IN-VITRO ACTIVITY; LINKED 5-TRIAZOLYLMETHYL OXAZOLIDINONES; CONFORMATIONALLY CONSTRAINED ANALOGS; MITOCHONDRIAL PROTEIN-SYNTHESIS; MONOAMINE-OXIDASE-A; STAPHYLOCOCCUS-AUREUS; HIGHLY POTENT; ISOXAZOLINYL OXAZOLIDINONES; SUBSTITUTED OXAZOLIDINONES; TRICYCLIC OXAZOLIDINONES;
D O I
10.1016/j.bmc.2012.11.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oxazolidinones are a new and potent class of antimicrobial agents with activity mainly against Gram-positive strains. The commercial success of linezolid, the only FDA-approved oxazolidinone, has prompted many pharmaceutical companies to devote resources to this area of investigation. Until now, four types of chemical modifications of linezolid and oxazolidinone-type antibacterial agents, including modification on each of the A-(oxazolidinone), B-(phenyl), and C-(morpholine) rings as well as the C-5 side chain of the A-ring substructure, have been described. Division into sections according to side chain modification or the type of ring will be used throughout this review, although the process of synthesis usually involves the simultaneous modification of several elements of the linezolid substructure; therefore, assignment into the appropriate section depends on the structure-activity relationships (SAR) studies. This review makes an attempt to summarise the work carried out in the period from 2006 until mid-2012. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:577 / 591
页数:15
相关论文
共 116 条
[1]  
Agarwal S.K., [No title captured], Patent No. [US 7217,726 B2, 7217726]
[2]   1,2-amino alcohols and their heterocyclic derivatives as chiral auxiliaries in asymmetric synthesis [J].
Ager, DJ ;
Prakash, I ;
Schaad, DR .
CHEMICAL REVIEWS, 1996, 96 (02) :835-875
[3]  
Barbachyn M.R., 2010, ANGEW CHEM INT EDIT, V2003, P42
[4]   Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model [J].
Barman, Tarani Kanta ;
Pandya, Manisha ;
Mathur, Tarun ;
Bhadauriya, Tripti ;
Rao, Madhvi ;
Khan, Seema ;
Singhal, Smita ;
Bhateja, Pragya ;
Sood, Ruchi ;
Malhotra, Sunita ;
Das, Biswajit ;
Paliwal, Jyoti ;
Bhatnagar, Pradip Kumar ;
Upadhyay, Dilip J. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (03) :280-284
[5]   How many modes of action should an antibiotic have? [J].
Broetz-Oesterhelt, Heike ;
Brunner, Nina A. .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) :564-573
[6]   Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety [J].
Chandrakantha, B. ;
Shetty, Prakash ;
Nambiyar, Vijesh ;
Isloor, Nishitha ;
Isloor, Arun M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (03) :1206-1210
[7]  
Cho Y.L., 2008, PCT, Patent No. [PCT WO2008069619, 2008069619]
[8]  
Cho Y. L., 2011, Patent, Patent No. [US 20110178293, 20110178293]
[9]   Synthesis and SAR of novel conformationally restricted oxazolidinones possessing Gram-positive and fastidious Gram-negative antibacterial activity. Part 2: Amino substitutions on heterocyclic D-ring system [J].
Choy, Allison L. ;
Prasad, J. V. N. Vara ;
Boyer, Frederick E. ;
Huband, Michael D. ;
Dermyer, Michael R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) :4699-4702
[10]   Synthesis and biological activity of novel oxazolidinones [J].
Das, Biswajit ;
Rajarao, A. V. S. ;
Rudra, Sonali ;
Yadav, Ajay ;
Ray, Abhijit ;
Pandya, Manisha ;
Rattan, Ashok ;
Mehta, Anita .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (22) :6424-6428